Skip to content

BPHARMA

Active
Private limited companyfounded 201214 yrs activeRue de Fromiée(GER) 128, 6280 Gerpinnes, BelgiumKBO/BCE: BE 0843.945.431
Summary

BPHARMA has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €536,490 and a net result of €101,700. Equity is growing by ~24.7% per year across the filed fiscal years. Its solvency ranks better than 58% of 18626 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability57▲+10
Solvency68▲+8
Growth78=
Track record100
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30,000 at 30 days acceptable
Liquidity short (current ratio 0.19 against 0.27 in 2024; short-term debt: 9.3% and cash: 1.1% of total assets), and 56.8% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
43.2%
Return on assets
8.2%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 14 years 0 20 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-07-2026, 21 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
21 d early
2024
16 d early
2023
26 d early
2022
12 d early
2021
20 d early
2020
23 d early
2019
27 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 13 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 11 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

BPHARMA was incorporated on 24 February 2012.1 Total assets rose from EUR 116,657 in 2018 to EUR 1.2 million in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€101,700▲ 50.0%
2024 · €67,790
Working capital
-€93,891▲ 1.1%
2024 · -€94,900
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€37,560▼ 9.1%€40,363▲ 7.5%€39,486▼ 2.2%€28,276▼ 28.4%€31,842▲ 12.6%
Net result€39,811above the sector's middle half▼ 68.0%€51,187above the sector's middle half▲ 28.6%€87,166above the sector's middle half▲ 70.3%€67,790above the sector's middle half▼ 22.2%€101,700above the sector's middle half▲ 50.0%
Equity€238,647above the sector's middle half▲ 20.0%€289,834above the sector's middle half▲ 21.4%€377,000above the sector's middle half▲ 30.1%€434,790above the sector's middle half▲ 15.3%€536,490above the sector's middle half▲ 23.4%
Total assets€1.2mabove the sector's middle half▼ 0.2%€1.2mabove the sector's middle half▼ 0.5%€1.2mabove the sector's middle half▲ 2.3%€1.3mabove the sector's middle half▲ 0.3%€1.2mabove the sector's middle half▼ 0.8%
Debt€987,272▼ 4.1%€929,476▼ 5.9%€870,516▼ 6.3%€816,968▼ 6.2%€705,707▼ 13.6%
Working capital-€66,608below the sector's middle half▼ 22.6%-€68,245below the sector's middle half▼ 2.5%-€58,268below the sector's middle half▲ 14.6%-€94,900below the sector's middle half▼ 62.9%-€93,891below the sector's middle half▲ 1.1%
Solvency19.5%within the sector's middle half▲ 3.3pp23.8%within the sector's middle half▲ 4.3pp30.2%within the sector's middle half▲ 6.4pp34.7%within the sector's middle half▲ 4.5pp43.2%within the sector's middle half▲ 8.5pp
Current ratio0.23below the sector's middle half▼ 0.030.19below the sector's middle half▼ 0.040.33below the sector's middle half▲ 0.150.27below the sector's middle half▼ 0.060.19below the sector's middle half▼ 0.08
Return on assets (ROA)3.2%within the sector's middle half▼ 6.9pp4.2%within the sector's middle half▲ 1.0pp7.0%within the sector's middle half▲ 2.8pp5.4%within the sector's middle half▼ 1.6pp8.2%within the sector's middle half▲ 2.8pp
above within below the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
€0€50,000€100,000Operating result 2021: €37,560€37,560Net result 2021: €39,811€39,811Operating result 2022: €40,363€40,363Net result 2022: €51,187€51,187Operating result 2023: €39,486€39,486Net result 2023: €87,166€87,166Operating result 2024: €28,276€28,276Net result 2024: €67,790€67,790Operating result 2025: €31,842€31,842Net result 2025: €101,700€101,70020212022202320242025€0€50,000€100,000Operating result 2023: €39,486€39,500Net result 2023: €87,166€87,200Operating result 2024: €28,276€28,300Net result 2024: €67,790€67,800Operating result 2025: €31,842€31,800Net result 2025: €101,700€102,000202320242025
The operating result recovers in 2025; 2025 is 13% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.2m
Fixed assets €1.2m ▲ 0.3%
Current assets €21,512 ▼ 38.8%
Equity and liabilities €1.2m
Equity €536,490 ▲ 23.4%
Debt €705,707 ▼ 13.6%
Debt's share of the balance-sheet total falls from 65.3% to 56.8%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€34,726▲
2024 · €29,810
Cash flow
€104,585▲
2024 · €69,324
Debt to equity
1.32▼
2024 · 1.88
ROE
19.0%▲
2024 · 15.6%
Interest coverage
3.39▲
2024 · 2.62
Debt ≤ 1 year
€115,402▼
2024 · €130,028
Debt > 1 year
€589,681▼
2024 · €686,940
Income taxes
€5,793▲
2024 · €4,781
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 51 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.3m€1.2m▼
Fixed assets21/28€1.2m€1.2m▲
Tangible fixed assets22/27€13,026€17,083▲
Furniture and vehicles24-€5,590
Other tangible fixed assets26€13,026€11,492▼
Financial fixed assets28€1.2m€1.2m=
Current assets29/58€35,128€21,512▼
Amounts receivable within one year40/41€12,152€3,266▼
Trade receivables40€0-
Other amounts receivable41€12,152€3,266▼
Cash at bank and in hand54/58€18,347€13,565▼
Deferred charges and accrued income490/1€4,629€4,681▲
Equity and liabilities
Total equity and liabilities10/49€1.3m€1.2m▼
Equity10/15€434,790€536,490▲
Contributions10/11€6,200€6,200=
Reserves13€140,860€140,860=
Non-distributable reserves130/1€1,860€1,860=
Reserves not available under the articles1311€1,860€1,860=
Distributable reserves133€139,000€139,000=
Profit (loss) carried forward14€287,730€389,430▲
Amounts payable17/49€816,968€705,707▼
Amounts payable after more than one year17€686,940€589,681▼
Financial debts170/4€686,940€589,681▼
Amounts payable within one year42/48€130,028€115,402▼
Current portion of amounts payable after more than one year42€101,357€102,034▲
Trade debts44€10,542€10,958▲
Suppliers440/4€10,542€10,958▲
Taxes, remuneration and social security45€8,629€2,411▼
Taxes450/3€8,629€2,411▼
Remuneration and social security454/9€0-
Other amounts payable47/48€9,500€0▼
Accrued charges and deferred income492/3-€624
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,534€2,884▲
Other operating charges640/8€1,036€1,069▲
Gross operating margin9900€30,846€35,795▲
Operating profit (loss)9901€28,276€31,842▲
Financial income75/76B€55,688€85,902▲
Recurring financial income75€55,688€85,902▲
Financial charges65/66B€11,393€10,251▼
Recurring financial charges65€11,393€10,251▼
Profit (loss) for the period before taxes9903€72,571€107,493▲
Income taxes67/77€4,781€5,793▲
Profit (loss) for the period9904€67,790€101,700▲
Profit (loss) for the period to be appropriated9905€67,790€101,700▲
Appropriation of the result
Profit (loss) to be appropriated9906€287,730€389,430▲
Profit (loss) brought forward from the previous period14P€219,940€287,730▲
Transfer from equity791/2€10,000€0▼
Transfer to equity691/2€0-
To other reserves6921€0-
Profit to be distributed694/7€10,000€0▼
Return on contributions (dividend)694€10,000€0▼

The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Non-recurring operating income76A€2,674-----
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2,601€2,601€782€1,534€2,884▲ 88.0%
Other operating charges640/8€1,525€928€1,085€1,036€1,069▲ 3.2%
Gross operating margin9900€41,687€43,891€41,353€30,846€35,795▲ 16.0%
Operating profit (loss)9901€37,560€40,363€39,486€28,276€31,842▲ 12.6%
Financial income75/76B€25,000€34,700€72,304€55,688€85,902▲ 54.3%
Recurring financial income75€25,000€34,700€72,304€55,688€85,902▲ 54.3%
Financial charges65/66B€13,616€12,874€12,118€11,393€10,251▼ 10.0%
Recurring financial charges65€13,616€12,874€12,118€11,393€10,251▼ 10.0%
Profit (loss) for the period before taxes9903€48,944€62,188€99,672€72,571€107,493▲ 48.1%
Income taxes67/77€9,133€11,002€12,505€4,781€5,793▲ 21.2%
Profit (loss) for the period9904€39,811€51,187€87,166€67,790€101,700▲ 50.0%
Profit (loss) for the period to be appropriated9905€39,811€51,187€87,166€67,790€101,700▲ 50.0%
Line20212022202320242025Change
Assets
Total assets20/58€1.2m€1.2m€1.2m€1.3m€1.2m▼ 0.8%
Fixed assets21/28€1.2m€1.2m€1.2m€1.2m€1.2m▲ 0.3%
Tangible fixed assets22/27€2,601-€14,561€13,026€17,083▲ 31.1%
Furniture and vehicles24€2,601---€5,590-
Other tangible fixed assets26--€14,561€13,026€11,492▼ 11.8%
Financial fixed assets28€1.2m€1.2m€1.2m€1.2m€1.2m=
Current assets29/58€19,715€15,707€29,352€35,128€21,512▼ 38.8%
Amounts receivable within one year40/41-€586€11,067€12,152€3,266▼ 73.1%
Trade receivables40--€211€0--
Other amounts receivable41-€586€10,856€12,152€3,266▼ 73.1%
Cash at bank and in hand54/58€15,064€10,539€13,654€18,347€13,565▼ 26.1%
Deferred charges and accrued income490/1€4,650€4,582€4,631€4,629€4,681▲ 1.1%
Equity and liabilities
Total equity and liabilities10/49€1.2m€1.2m€1.2m€1.3m€1.2m▼ 0.8%
Equity10/15€238,647€289,834€377,000€434,790€536,490▲ 23.4%
Contributions10/11€6,200€6,200€6,200€6,200€6,200=
Reserves13€50,860€100,860€150,860€140,860€140,860=
Non-distributable reserves130/1€1,860€1,860€1,860€1,860€1,860=
Reserves not available under the articles1311€1,860€1,860€1,860€1,860€1,860=
Distributable reserves133€49,000€99,000€149,000€139,000€139,000=
Profit (loss) carried forward14€181,587€182,774€219,940€287,730€389,430▲ 35.3%
Amounts payable17/49€987,272€929,476€870,516€816,968€705,707▼ 13.6%
Amounts payable after more than one year17€900,949€845,525€782,896€686,940€589,681▼ 14.2%
Financial debts170/4€900,949€845,525€782,896€686,940€589,681▼ 14.2%
Amounts payable within one year42/48€86,323€83,951€87,620€130,028€115,402▼ 11.2%
Current portion of amounts payable after more than one year42€60,089€60,830€68,032€101,357€102,034▲ 0.7%
Trade debts44€9,739€10,359€10,487€10,542€10,958▲ 3.9%
Suppliers440/4€9,739€10,359€10,487€10,542€10,958▲ 3.9%
Taxes, remuneration and social security45€6,719€12,763€9,101€8,629€2,411▼ 72.1%
Taxes450/3€6,719€11,747€7,990€8,629€2,411▼ 72.1%
Remuneration and social security454/9-€1,016€1,112€0--
Other amounts payable47/48€9,775--€9,500€0▼ 100%
Accrued charges and deferred income492/3----€624-
Line20212022202320242025Change
Profit (loss) for the period9904€39,811€51,187€87,166€67,790€101,700▲ 50.0%
+ Depreciation and write-downs630€2,601€2,601€782€1,534€2,884▲ 88.0%
Operating cash flow (approximation)€42,412€53,788€87,948€69,324€104,585▲ 50.9%
Investment in fixed assets (approximation)-€0-€15,343€0-€6,941-
Change in cash--€4,526€3,115€4,694-€4,782▼ 202%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
10-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Equity above €500,000Eq €536,490 ▲23.4%
6 profitable years in a row build equity to €536,490.
15-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
05-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
19-07
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
11-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial Equity above €200,000Eq €238,647 ▲20%
2 profitable years in a row build equity to €238,647.
08-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial Back to profitnet €124,413
Net result €124,413 after one loss-making year.
31-12
Financial Equity above €150,000Eq €198,836 ▲167%
Equity rises from €74,423 to €198,836.
27-08
NBB filing Annual accounts filed
fiscal year 2019 · full schema · 27 days late
2019
31-12
Financial Weakest financial yearnet -€2,972
Net result drops to -€2,972, the lowest in the series; recovery starts the following year.
Show earlier events
29-08
NBB filing Annual accounts filed
fiscal year 2018 · full schema · 29 days late
2018
28-08
NBB filing Annual accounts filed
fiscal year 2017 · full schema · 28 days late
2017
25-08
NBB filing Annual accounts filed
fiscal year 2016 · full schema · 25 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gerpinnes · 1 establishment unit since 2012
seat establishment The establishment unit on the map
Ground area
1,838 m²
Building footprint
198 m²
Volume, LiDAR
1,315 m³
2 parcels, Wallonia · tallest building 11.2 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Rue Sart-les-Moulins 52, 6044 Charleroi
Manufacture of food products
since 20122.207.939.239
2 parcels
Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
52025C0470/00D004 Wallonia 1,107 m² 1 · 134 m² 7.7 m · 2 fl.
52061C0170/00B004 Wallonia 731 m² 1 · 64 m² 11.2 m · 3 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 holding

Owners 0

The accounts to 31-12-2025 list no shareholders, and no other source names one.

Holdings 1

According to the 2025 annual accounts of BPHARMA and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 3,337 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded24-02-2012
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
10860Manufacture of food products
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
46150Agents in the wholesale of furniture, household goods and hardware
46460Wholesale of pharmaceutical and medical goods
68110Buying and selling of own real estate
E-invoicing
Reachable via Peppol
Peppol ID 0208:0843945431
Registered 27-11-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.